Galapagos NV
GLPG
$25.44
Share price
-1.09%
Change (1 day)
-40.00%
Change (1 year)
Categories
Market capitalization of Galapagos NV (GLPG)
Market cap: $1.70 Billion
As of June 2024 Galapagos NV has a market cap of $1.70 Billion. This makes Galapagos NV the world's 4337th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Galapagos NV from 2008 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $1.70 B | -36.44% |
| 2023 | $2.67 B | -8.32% |
| 2022 | $2.92 B | -20.02% |
| 2021 | $3.65 B | -43.58% |
| 2020 | $6.47 B | -52.07% |
| 2019 | $13.50 B | 169.16% |
| 2018 | $5.01 B | 4.51% |
| 2017 | $4.80 B | 61.16% |
| 2016 | $2.97 B | 20.89% |
| 2015 | $2.46 B | 331.92% |
| 2014 | $0.57 B | -8.94% |
| 2013 | $0.62 B | 10.91% |
| 2012 | $0.56 B | 58.44% |
| 2011 | $0.35 B | -16.16% |
| 2010 | $0.42 B | 66.9% |
| 2009 | $0.25 B | 148.04% |
| 2008 | $0.10 B |
End of Day market cap according to different sources
On Jun 16th, 2024 the market cap of Galapagos NV was reported to be:
$1.67 Billion
$1.68 Billion
$1.70 Billion
$1.67 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $350.26 B | 20,471.66% | 🇺🇸 USA |
 Abbott Laboratories ABT | $180.36 B | 10,493.04% | 🇺🇸 USA |
 AbbVie ABBV | $297.70 B | 17,384.73% | 🇺🇸 USA |
 Sanofi SNY | $118.92 B | 6,884.60% | 🇫🇷 France |
 Merck MRK | $327.94 B | 19,160.78% | 🇺🇸 USA |
 AstraZeneca AZN | $246.76 B | 14,393.06% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $84.01 B | 4,834.30% | 🇬🇧 UK |
 Fortress Biotech
FBIO | $37.24 M | -97.81% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $19.56 B | 1,049.07% | 🇮🇱 Israel |